Efficacy of an extracorporeal flat-plate bioartificial liver in treating fulminant hepatic failure

Journal of Surgical Research

Volumn 111, Issue 1, 2003, Pages 53-62

  Shito, Masaya ^a   Tilles, Arno W ^a   Tompkins, Ronald G ^a   Yarmush, Martin L ^a   Toner, Mehmet ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Animal model; Bioartificial liver; Bioreactor; D galactosamine; Hepatocyte; Liver failure

Indexed keywords

GALACTOSAMINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTIFICIAL LIVER; CANNULATION; CAROTID ARTERY; CONTROLLED STUDY; JUGULAR VEIN; LIVER FAILURE; LIVER HISTOLOGY; LIVER INJURY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SURVIVAL;

EID: 0038385418     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-4804(03)00048-9     Document Type: Article

References (44)

1. Bismuth H., Samuel D., Castaing D., Adam R., Saliba F., Johann M., Azoulay D., Ducot B., Chiche L. Orthotopic liver transplantation in fulminant and subfulminant hepatitis. The Paul Brousse experience. Ann. Surg. 222:1995;109.
2. Yarmush M.L., Dunn J.C.Y., Tompkins R.G. Assessment of artificial liver support technology. Cell Transplant. 1:1992;323.
3. Kamohara Y., Rozga J., Demetriou A.A. Artificial liver review and Cedars-Sinai experience . J.Hepatobiliary Pancreat. Surg. 5:1998;273.
4. Ellis A.J., Hughes R.D., Wendon J.A., Dunne J., Langley P.G., Kelly J.H., Gislason G.T., Sussman N.L., Williams R. Pilot-controlled trial of the extracorporeal liver assist device in acute liver failure. Hepatology. 24:1996;1446.
5. Watanabe F.D., Mullon C.J., Hewitt W.R., Arkadopoulos N., Kahaku E., Eguchi S., Khalili T., Arnaout W., Shackleton C.R., Rozga J., Solomon B., Demetriou A.A. Clinical experience with a bioartificial liver in the treatment of severe liver failure. A phase I clinical trial. Ann. Surg. 225:1997;484.
6. Hay P.D., Veitch A.R., Smith M.D., Cousins R.B., Gaylor J.D. Oxygen transfer in a diffusion-limited hollow fiber bioartificial liver. Artif. Organs. 24:2000;278.
7. Hay P.D., Veitch A.R., Gaylor J.D. Oxygen transfer in a convection-enhanced hollow fiber bioartificial liver. Artif. Organs. 25:2001;119.
8. Catapano G. Mass transfer limitations to the performance of membrane bioartificial liver support devices. Int. J. Artif. Organs. 19:1996;18.
9. Gerlach J.C., Encke J., Hole O., Muller C., Ryan C.J., Neuhaus P. Bioreactor for a larger scale hepatocyte in-vitro perfusion. Transplantation. 58:1994;984.
10. Flendrig L.M., la Soe J.W., Jorning G.G., Steenbeek A., Karlsen O.T., Bovee W.M., Ladiges N.C., te Velde A.A., Chamuleau R.A. In vitro evaluation of a novel bioreactor based on an integral oxygenator and a spirally wound nonwoven polyester matrix for hepatocyte culture as small aggregates. J.Hepatol. 26:1997;1379.
11. Bader A., De Bartolo L., Haverich A. Initial evaluation of the performance of a scaled up flat membrane bioreactor (FMB) with pig liver cells. Crepaldi G., Demetriou A.A., Muraca M. Bioartificial Liver Support Systems The Critical Issues . 1997;36 CIC Edizioni Internazionali, Rome.
12. De Bartolo L., Jarosch-Von Schweder G., Haverich A., Bader A. A novel full-scale flat membrane bioreactor utilizing porcine hepatocytes cell viability and tissue-specific functions . Biotechnol. Prog. 16:2000;102.
13. Roy P., Baskaran H., Tilles A.W., Yarmush M.L., Toner M. Analysis of oxygen transport to hepatocytes in a flat-plate microchannel bioreactor. Ann. Biomed. Eng. 29:2001;947.
14. Tilles A.W., Balis U.J., Baskaran H., Yarmush M.L., Toner M. Internal membrane oxygenation removes substrate oxygen limitations in a small-scale flat-plate hepatocyte bioreactor. Ikada Y., Ohshima N. International Symposium on Tissue Engineering for Therapeutic Use 5. 2001;59 Elsevier, Amsterdam.
15. Tilles A.W., Baskaran H., Roy P., Yarmush M.L., Toner M. Effects of oxygenation and flow on the viability and function of rat hepatocytes co-cultured in a microchannel flat-plate bioreactor. Biotechnol. Bioeng. 73:2001;379.
16. Roy P., Washizu J., Tilles A.W., Yarmush M.L., Toner M. Effect of flow on the detoxification function of rat hepatocytes in a bioartificial liver reactor. Cell Transplant. 10:2001;609.
17. Shito M., Kim N.H., Baskaran H., Tilles A.W., Tompkins R.G., Yarmush M.L., Toner M. In vitro and in vivo evaluation of albumin synthesis rate of porcine hepatocytes in a flat-plate bioreactor. Artif. Organs. 25:2001;571.
18. Shito M., Balis U., Tompkins R., Yarmush M., Toner M. A fulminant hepatic failure model in the rat involvement of interleukin-1β and tumor necrosis factor α Dig. Dis. Sci. 46:2001;1700.
19. Gregory P.G., Connolly C.K., Toner M., Sullivan S.J. In vitro characterization of porcine hepatocyte function. Cell Transplant. 9:2000;1.
20. Steen R.G., MacDonald C.G., Weaver A.L., Pitt A.M. Rapid fluorescence quantitation of plasmid miniprep DNA. BioTechniques. 15:1993;932.
21. Gerlach J.C. Development of a hybrid liver support system a review . Int. J. Artif. Organs. 19:1996;645.
22. Nyberg S.L., Misra S.P. Hepatocyte liver-assist systems - a clinical update. Mayo Clin. Proc. 73:1998;765.
23. Demetriou A.A., Rozga J., Podesta L., Lepage E., Morsiani E., Moscioni A.D., Hoffman A., McGrath M., Kong L., Rosen H., Villamil F., Woolf G., Vierling J., Makowka L. Early clinical experience with a hybrid bioartificial liver. Scand. J. Gastroenterol. Suppl. 208:1995;111.
24. Taguchi K., Matsushita M., Takahashi M., Uchino J. Development of a bioartificial liver with sandwiched-cultured hepatocytes between two collagen gel layers. Artif. Organs. 20:1996;178.
25. Rozga J., Williams F., Ro M.S., Neuzil D.F., Giorgio T.D., Backfisch G., Moscioni A.D., Hakim R., Demetriou A.A. Development of a bioartificial liver properties and function of a hollow-fiber module inoculated with liver cells . Hepatology. 17:1993;258.
26. Desille M., Corcos L., L'Helgoualc'h A., Fremond B., Campion J.P., Guillouzo A., Clement B. Detoxifying activity in pig livers and hepatocytes intended for xenotherapy. Transplantation. 68:1999;1437.
27. Behnia K., Bhatia S., Jastromb N., Balis U., Sullivan S., Yarmush M.L., Toner M. Xenobiotic metabolism by cultured primary porcine hepatocytes. Tissue Eng. 6:2000;467.
28. Martin U., Winkler M.E., Id M., Radeke H., Arseniev L., Takeuchi Y., Simon A.R., Patience C., Haverich A., Steinhoff G. Productive infection of primary human endothelial cells by pig endogenous retrovirus (PERV). Xenotransplantation. 7:2000;138.
29. Patience C., Takeuchi Y., Weiss R.A. Infection of human cells by an endogenous retrovirus of pigs. Nat. Med. 3:1997;282.
30. Kuddus R., Patzer J.F., Lopez R., Mazariegos G.V., Meighen B., Kramer D.J., Fung J.J., Rao A.S. Valuation of transmission of porcine endogenous retrovirus into patients subjected to hemoperfusion using an extracorporeal bioartificial liver support system. Transplant. Proc. 33:2001;1976.
31. Falasca E., Adami V., Astori G., Donini A., Biffoni F., Degrassi A., Botta G.A., Pipan C. Porcine endogenous retrovirus does not infect human cells using a bioartificial liver model system. Transplant. Proc. 33:2001;1780.
32. Sussman N.L., Chong M.G., Koussayer T., He D.E., Shang T.A., Whisennand H.H., Kelly J.H. Reversal of fulminant hepatic failure using an extracorporeal liver assist device. Hepatology. 16:1992;60.
33. Jauregui H.O., Mullon C.J., Trenkler D., Naik S., Santangini H., Press P., Muller T.E., Solomon B.A. In vivo evaluation of a hollow fiber liver assist device. Hepatology. 21:1995;460.
34. Kaplowitz N. Mechanisms of liver cell injury. J.Hepatol. 32:2000;39.
35. Denis J., Delorme M.L., Boschat M., Nordlinger B., Opolon P. Respective roles of ammonia, amino acids, and medium-sized molecules in the pathogenesis of experimentally induced acute hepatic encephalopathy. J.Neurochem. 40:1983;10.
36. Flendrig L.M., Chamuleau R.A., Maas M.A., Daalhuisen J., Hasset B., Kilty C.G., Doyle S., Ladiges N.C., Jorning G.G., la Soe J.W., Sommeijer D., te Velde A.A. Evaluation of a novel bioartificial liver in rats with complete liver ischemia treatment efficacy and species-specific alpha-GST detection to monitor hepatocyte viability . J.Hepatol. 30:1999;311.
37. Sielaff T.D., Hu M.Y., Amiot B., Rollins M.D., Rao S., McGuire B., Bloomer J.R., Hu W.S., Cerra F.B. Gel-entrapment bioartificial liver therapy in galactosamine hepatitis. J.Surg. Res. 59:1995;179.
38. Cuervas-Mons V., Colas A., Rivera J.A., Prados E. In vivo efficacy of a bioartificial liver in improving spontaneous recovery from fulminant hepatic failure a controlled study in pigs . Transplantation. 69:2000;337.
39. Uchino J., Tsuburaya T., Kumagai F., Hase T., Hamada T., Komai T., Funatsu A., Hashimura E., Nakamura K., Kon T. A hybrid bioartificial liver composed of multiplated hepatocyte monolayers. ASAIO Trans. 34:1988;972.
40. Flendrig L.M., te Velde A.A., Chamuleau R.A. Semipermeable hollow fiber membranes in hepatocyte bioreactors a prerequisite for a successful bioartificial liver . Artif. Organs. 21:1997;1177.
41. Catapano G., De Bartolo L., Lombardi C.P., Drioli E. The effect of oxygen transport resistances on the viability and functions of isolated rat hepatocytes. Int. J. Artif. Organs. 19:1996;61.
42. Bader A., De Bartolo L., Haverich A. High level benzodiazepine and ammonia clearance by flat membrane bioreactors with porcine liver cells. J.Biotechnol. 81:2000;95.
43. Bhatia S.N., Balis U.J., Yarmush M.L., Toner M. Effect of cell-cell interactions in preservation of cellular phenotype cocultivation of hepatocytes and nonparenchymal cells . FASEB J. 13:1999;1883.
44. Borel Rinkes I.H., Toner M., Sheeha S.J., Tompkins R.G., Yarmush M.L. Long-term functional recovery of hepatocytes after cryopreservation in a three-dimensional culture configuration. Cell Transplant. 1:1992;281.